LRRC37B2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.689600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.709800E-01
Normal-vs-Stage2
3.035600E-01
Normal-vs-Stage3
1.040440E-02
Normal-vs-Stage4
3.153400E-01
Stage1-vs-Stage2
4.909800E-01
Stage1-vs-Stage3
1.826080E-02
Stage1-vs-Stage4
7.212000E-01
Stage2-vs-Stage3
3.683600E-02
Stage2-vs-Stage4
8.200200E-01
Stage3-vs-Stage4
2.056200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.039200E-01
Normal-vs-AfricanAmerican
6.934000E-01
Normal-vs-Asian
5.303600E-02
Caucasian-vs-AfricanAmerican
7.149400E-01
Caucasian-vs-Asian
9.732300E-02
AfricanAmerican-vs-Asian
1.063760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.166400E-01
Normal-vs-Female
4.034800E-01
Male-vs-Female
9.725000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.987600E-01
Normal-vs-Age(41-60Yrs)
9.450600E-01
Normal-vs-Age(61-80Yrs)
3.110400E-01
Normal-vs-Age(81-100Yrs)
1.142030E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.592600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.435400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.466100E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.416940E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.248080E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.395030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.916100E-02
Normal-vs-Daily Drinker
4.454000E-01
Normal-vs-Weekly Drinker
1.149420E-01
Normal-vs-Occasional Drinker
8.403200E-01
Normal-vs-Social Drinker
9.094200E-01
Non Drinker-vs-Daily Drinker
2.746600E-01
Non Drinker-vs-Weekly Drinker
4.229600E-01
Non Drinker-vs-Occasional Drinker
8.138800E-03
Non Drinker-vs-Social Drinker
1.793660E-02
Daily Drinker-vs-Weekly Drinker
6.571400E-01
Daily Drinker-vs-Occasional Drinker
8.773600E-02
Daily Drinker-vs-Social Drinker
2.252400E-01
Weekly Drinker-vs-Occasional Drinker
3.115900E-02
Weekly Drinker-vs-Social Drinker
7.845900E-02
Occasional Drinker-vs-Social Drinker
5.836200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.501360E-01
Normal-vs-Grade 2
2.884000E-02
Normal-vs-Grade 3
6.164800E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.034360E-01
Grade 1-vs-Grade 3
1.353180E-01
Grade 1-vs-Grade 4
1.501360E-01
Grade 2-vs-Grade 3
7.515200E-01
Grade 2-vs-Grade 4
2.884000E-02
Grade 3-vs-Grade 4
6.164800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.053800E-01
Normal-vs-NonDiabetic
5.899600E-01
Diabetic-vs-NonDiabetic
7.688100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.713600E-01
Normal-vs-NoPancreatitis
4.509800E-01
Pancreatitis-vs-NoPancreatitis
7.953200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.208800E-01
Normal-vs-N1
3.308600E-01
N0-vs-N1
5.232200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.182400E-01
Normal-vs-TP53-NonMutant
8.664800E-01
TP53-Mutant-vs-TP53-NonMutant
1.968010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
